Top Clinical Trials companies in South Korea by Cash and Short-Term Investments
South Korea
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 581.76 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD 185.18 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 3 |
USD 105.39 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 4 |
USD 84.95 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 5 |
USD 74.87 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 6 |
USD 69.19 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 7 |
USD 58.52 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 8 |
USD 55.76 M
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
| 9 |
USD 54.65 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 10 |
USD 49.52 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 11 |
USD 39.46 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 12 |
USD 38.66 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 13 |
USD 19.91 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 14 |
USD 8.66 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 15 |
USD 7.67 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 16 |
USD 3.83 M
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 17 |
USD 3.08 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Cash and Short-Term Investments ?
The Clinical Trials company in South Korea with the highest Cash and Short-Term Investments is Celltrion, Inc. (KSE: 068270.KS) at USD 581.76 M.
-
Which Clinical Trials company in South Korea has the lowest Cash and Short-Term Investments ?
The Clinical Trials company in South Korea with the lowest Cash and Short-Term Investments is Samjin Pharmaceuticals Co., Ltd. (KSE: 005500.KS) at USD 3.08 M.
-
What are the top 10 Clinical Trials companies in South Korea by Cash and Short-Term Investments ?
The top 10 Clinical Trials companies in South Korea by Cash and Short-Term Investments are Celltrion, Inc., SK Biopharmaceuticals Co., Ltd., Enzychem Lifesciences Corporation, ALTEOGEN Inc., Oscotec Inc., ST Pharm Co.,Ltd., Boditech Med Inc., MedPacto, Inc., ABL Bio Inc. and Genexine, Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Cash and Short-Term Investments ?
The bottom 10 Clinical Trials companies in South Korea by Cash and Short-Term Investments are Samjin Pharmaceuticals Co., Ltd., Peptron, Inc., GeneOne Life Science, Inc., Gencurix Inc., OliX Pharmaceuticals,Inc, Anterogen.Co.,Ltd., CrystalGenomics, Inc., Genexine, Inc., ABL Bio Inc. and MedPacto, Inc..
